Biomimetic liposomes in drug delivery: from design mechanisms to applications

Abstract

Recent advancements in nanocarriers, particularly liposomes, have shown promising prospects for enhancing the pharmacokinetics, biodistribution, and therapeutic efficacy of chemotherapeutic drugs. However, liposome-based drug delivery systems are often constrained by high immunogenicity, poor targeting efficiency, and limited functional capabilities. In this context, the exploration of biomimetic liposomes has revealed their potential in targeted therapy, immune camouflage, immune modulation, gene delivery and vaccine development. By integrating the beneficial features of functional molecules and natural cell membrane components with the unique properties of liposomes, biomimetic liposomes have demonstrated considerable promise in drug delivery. This review aims to emphasize recent progress in biomimetic liposomes and systematically elucidate their design mechanisms and preparation methods. Additionally, it provides a comprehensive overview of the current applications of biomimetic liposomes as an innovative drug delivery platform, with the goal of advancing knowledge for their effective utilization.

Graphical abstract: Biomimetic liposomes in drug delivery: from design mechanisms to applications

Article information

Article type
Review Article
Submitted
22 Aug 2025
First published
09 Dec 2025
This article is Open Access
Creative Commons BY license

Chem. Soc. Rev., 2026, Advance Article

Biomimetic liposomes in drug delivery: from design mechanisms to applications

Z. Li, M. Li and J. Lu, Chem. Soc. Rev., 2026, Advance Article , DOI: 10.1039/D5CS00440C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements